Rif S. El-Mallakh, MD

Depression Center, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, Kentucky; Corresponding author: Rif S. El-Mallakh, MD, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, 401 East Chestnut St, Ste 610, Louisville, KY 40202 ([email protected]).

Asenapine, Aggression, and Affinity

Letter to the Editor

Asenapine, Aggression, and Affinity

September 28, 2022

Dr El-Mallakh comments on a recent study by Citrome et al and discusses his group’s research on antiaggression effects of clozapine.

Rif S. El-Mallakh

Review Article

Prolactin Elevations and Permeability Glycoprotein

May 16, 2019

Why do some antipsychotic medications such as risperidone or paliperidone have a tendency to increase prolactin levels? The key lies in their high affinity with permeability glycoprotein. Read this...

Rif S. El-Mallakh, Justin Watkins

Commentary

Innovation in the Treatment of Bipolar Depression

October 28, 2014

Rif S. El-Mallakh

Original Research

Antidepressant Discontinuation in Bipolar Depression: A Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Randomized Clinical Trial of Long-Term Effectiveness and Safety

April 15, 2010

S. Nassir Ghaemi, Michael M. Ostacher, Rif S. El-Mallakh, et al

Original Research

Clinical Implications of Genetic Variation in the Serotonin Transporter Promoter Region: A Review

June 17, 2009

Nicole S. Luddington, Anitha Mandadapu, Margaret Husk, et al

Letter to the Editor

Serious Rash With Lamotrigine After Carbamazepine Discontinuation: A Case Report

March 15, 2005

Anton A. Subuh Surja, Kathryn E. Brotzge, Rif S. El-Mallakh

Letter to the Editor

Rapid Fade of Antidepressant Effect of Nefazodone in Bipolar Depression

August 1, 1999

Rif S. El-Mallakh

Letter to the Editor

Can Long-Term Antidepressant Use Be Depressogenic?

April 30, 1999

Rif S. El-Mallakh, Courtney Waltrip, Christopher Peters